Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expression

被引:2
|
作者
Li, Xuesong [1 ,2 ]
Li, Jiazhuang [1 ]
Liu, Ying [1 ]
Sun, Li [1 ]
Tai, Qingyang [1 ]
Gao, Shoubao [1 ]
Jiang, Weiwei [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Dept Oncol 2, Qiqihar, Heilongjiang, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Dept Oncol 2, 3 TaiShun St, Qiqihar, Heilongjiang, Peoples R China
关键词
Pancreatic cancer; KDM5B; Demethylation; STING; Immunity; Microenvironment remodeling; Antitumor ability; DEMETHYLASES;
D O I
10.1016/j.cyto.2023.156451
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: This study aims to investigate the effect of lysine demethylase 5B (KDM5B)-mediated dimethyl-lysine 4 histone H3 (H3K4me2) demethylation on immune microenvironment remodeling in pancreatic cancer. Methods: Pan 02 mouse pancreatic cancer cell lines were cultured and used to establish tumor model in vivo. RTqPCR and Western blot were used to detect the expression of stimulator of interferon gene (STING) and KDM5B in pancreatic cancer tissues and Pan 02 cells. The specific demethylation domain of KDM5B was detected by isothermal titration calorimetry binding assay. The regulatory roles of KDM5B in cell apoptosis and remodeling of immune microenvironment in vitro and in vivo were explored after loss-of functions in KDM5B. Results: KDM5B was highly expressed but STING was poorly expressed in pancreatic cancer tissues and Pan 02 cells. After knockdown of KDM5B, CD8+ T cells recognized and killed Pan 02 cells, which promoted the infiltration of CD8+ T cells in Pan 02 cells, thus improving the anti-tumor ability. The PHD domain in KDM5B specifically bound to H3K4me2 peptide and inhibition of KDM5B induced STING expression. Knockdown of KDM5B up-regulated STING expression to promote apoptosis, thus regulating the immune microenvironment and inhibiting the growth of tumor in mice. Meanwhile, knockdown of KDM5B and STING simultaneously counteracted the knockdown effect of KDM5B. Conclusion: Inhibition of KDM5B can promote the expression of STING through H3K4me2 demethylation, which promoted the recognition and killing of Pan 02 cells by CD8+ T cells, thus improving the anti-tumor ability and regulating the immune microenvironment.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] EXPRESSION AND CLINICAL SIGNIFICANCE OF KDM5A, KDM5B, AND FOXO1 IN ENDOMETRIAL CANCER
    Gao, Yao
    Gao, Jun
    POLISH JOURNAL OF PATHOLOGY, 2024, 75 (02) : 83 - 96
  • [2] Targeting histone demethylase KDM5B for cancer treatment
    Fu, Yun-Dong
    Huang, Ming-Jie
    Guo, Jia-Wen
    You, Ya-Zhen
    Liu, Hong-Min
    Huang, Li-Hua
    Yu, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [3] Identification of the upstream regulators of KDM5B in gastric cancer
    Zhao, Long-Fei
    Qi, Feng-Yu
    Zhang, Jin-Ge
    Pang, Jing-Ru
    Ren, Hong-Mei
    Shen, Dan-Dan
    Zhao, Li-Juan
    Qi, Lin
    Liu, Hong-Min
    Zheng, Yi-Chao
    LIFE SCIENCES, 2022, 298
  • [4] KDM5B expression in cisplatin resistant neuroblastoma cell lines
    Belhajova, Marie
    Podhorska, Natalia
    Vicha, Ales
    Eckschlager, Tomas
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [5] Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
    Jose, Anmi
    Shenoy, Gautham G.
    Sunil Rodrigues, Gabriel
    Kumar, Naveena A. N.
    Munisamy, Murali
    Thomas, Levin
    Kolesar, Jill
    Rai, Ganesha
    Rao, Praveen P. N.
    Rao, Mahadev
    CANCERS, 2020, 12 (08) : 1 - 16
  • [6] KDM5B plays a central role in esophageal cancer progression
    Nishida, Naohiro
    Kano, Yoshihiro
    Koseki, Jun
    Konno, Masamitsu
    Kawamoto, Koichi
    Doki, Yuichiro
    Mori, Masaki
    Ishii, Hideshi
    CANCER RESEARCH, 2015, 75
  • [7] The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
    Metzler, Veronika M.
    de Brot, Simone
    Haigh, Daisy B.
    Woodcock, Corinne L.
    Lothion-Roy, Jennifer
    Harris, Anna E.
    Nilsson, Emeli M.
    Ntekim, Atara
    Persson, Jenny L.
    Robinson, Brian D.
    Khani, Francesca
    Laursen, Kristian B.
    Gudas, Lorraine J.
    Toss, Michael S.
    Madhusudan, Srinivasan
    Rakha, Emad
    Heery, David M.
    Rutland, Catrin S.
    Mongan, Nigel P.
    Jeyapalan, Jennie N.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [8] The role of KDM6A in pancreatic cancer immune microenvironment.
    Jin, Lin
    Yang, Jing
    Yi, Zhujun
    Kim, Hong S.
    Tian, Feng
    Shi, Jiaqi
    CANCER RESEARCH, 2021, 81 (22) : 86 - 87
  • [9] Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view
    Shokri, Gelareh
    Doudi, Shaghayegh
    Fathi-Roudsari, Mehrnoosh
    Kouhkan, Fatemeh
    Sanati, Mohammad-Hossein
    LEUKEMIA RESEARCH, 2018, 68 : 105 - 111
  • [10] Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance
    Cao, Yaquan
    Wu, Chunli
    Ma, Liying
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (01)